TCG Crossover Management »

Savara shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Savara (SVRA) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $38M 10M 3.78

More positions owned by TCG Crossover Management

Structure Therapeutics Adrs (GPCR)
Cogent Biosciences Comm (COGT)
Geron Corp Comm (GERN)
AN2 Therapeutics Comm (ANTX)
Savara Comm (SVRA)
Taysha Gene Therapies Comm (TSHA)
Kalvista Pharmaceuticals Comm (KALV)
Inhibrx Comm (INBX)
Aerovate Therapeutics Comm (AVTE)
Icosavax Comm
Compass Pathways Adrs (CMPS)
Ventyx Biosciences Comm (VTYX)
Tyra Biosciences Comm (TYRA)
Madrigal Pharmaceuticals Comm (MDGL)
Silence Therapeutics Adrs (SLN)

View all positions for TCG Crossover Management

Top funds holding Savara

NEA Management Company
Jennison Associates
Vanguard Group
Frazier Life Sciences Management
VR Adviser
Vivo Capital
Wellington Management Company
Henderson Group
Millennium Management
Nantahala Capital Management
Superstring Capital Management
Connor, Clark & Lunn Investment Management
Bank of New York Mellon
ClariVest Asset Management
Charles Schwab Investment Management

View all funds holding Savara